# COVID-19: NIAID Regulatory Support Center

> **NIH NIH N01** · TECHNICAL RESOURCES INTERNATIONAL, INC. · 2022 · $5,253,390

## Abstract

The purpose of this contract is to provide regulatory expertise and support to operate and manage the NIAID Regulatory Support Center (RSC) to provide a wide range of clinical research activities and programs for NIAID. The RSC provides comprehensive regulatory support to: 1) perform NIAID-funded and NIAID-sponsored domestic and international clinical trial research; 2) provide training in key functions of clinical trial research to NIAID staff, investigators, and collaborators; and 3) maintain all contract-associated data and records in the NIAID-Clinical Research Management System (N-CRMS), including the electronic submission of required regulatory information.  This project will provide regulatory support services for the COVID-19 clinical trial ACTIV-2 (Outpatient Monoclonal Antibodies And Other Therapies).

## Key facts

- **NIH application ID:** 10610718
- **Project number:** 272201700014C-P00018-9999-2
- **Recipient organization:** TECHNICAL RESOURCES INTERNATIONAL, INC.
- **Principal Investigator:** ASIMAH RAFI
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $5,253,390
- **Award type:** —
- **Project period:** 2022-04-15 → 2023-04-14

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10610718

## Citation

> US National Institutes of Health, RePORTER application 10610718, COVID-19: NIAID Regulatory Support Center (272201700014C-P00018-9999-2). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10610718. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*